Progression-free survival (PFS) as a measure of efficacy for anti-EGFR antibodies in recurrent/metastatic (R/M) squamous cell carcinoma of head and neck (SCCHN).
Krzysztof Misiukiewicz
No relevant relationships to disclose
Lewis Winder
No relevant relationships to disclose
Michael Parides
No relevant relationships to disclose
Marcelo Raul Bonomi
No relevant relationships to disclose
Marshall R. Posner
No relevant relationships to disclose